Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad Oncology End-December Treasury Position Of EUR 12.4 Mln

Feb 3 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY PROVIDES FOURTH QUARTER 2022 BUSINESS
UPDATE AND
2023 OUTLOOK
    * AS OF DECEMBER 31, 2022, COMPANY ENDED YEAR WITH AN
UNAUDITED
TREASURY POSITION OF EUR 12.4 MILLION ($13.3 MILLION)
    * NET CASH BURN DURING Q4 OF 2022 AMOUNTED TO EUR 1.0
MILLION
    * PROJECTS ITS EXISTING CASH AND CASH EQUIVALENTS SHOULD BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURE
REQUIREMENTS INTO Q4 OF 2023

Source text for Eikon:  ID:nGNX4V7SKT 
Further company coverage:  CYAD.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Celyad Oncology SA

See all news